The Variant rs145204276 of GAS5 is Associated with the Development and Prognosis of Gastric Cancer.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Gastrointestinal and Liver Diseases

• Publication date

  2018-03-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.15403/jgld.2014.1121.271.qjlPMID 29557411
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The lncRNA MALAT1 contributes to non‐small cell lung cancer development via modulating miR‐124/STAT3 axis

  2018cited by this paper
• LncRNA MALAT1 induces colon cancer development by regulating miR‐129‐5p/HMGB1 axis

  2018cited by this paper
• High expression of LncRNA CASC15 is a risk factor for gastric cancer prognosis and promote the proliferation of gastric cancer.

  2017cited by this paper
• Long Noncoding RNA GAS5 Suppresses Cell Growth and Epithelial–Mesenchymal Transition in Osteosarcoma by Regulating the miR‐221/ARHI Pathway

  2017cited by this paper
• LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p.

  2016cited by this paper
• Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer

  2016cited by this paper
• Long non-coding RNA GAS5 acts as a molecular sponge to regulate miR-23a in gastric cancer.

  2016cited by this paper
• LncRNA GAS5 contributes to lymphatic metastasis in colorectal cancer

  2016influential reference
• A novel mitosis-associated lncRNA, MA-linc1, is required for cell cycle progression and sensitizes cancer cells to Paclitaxel

  2015cited by this paper
• CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA

  2015cited by this paper
• lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer

  2015cited by this paper
• Clinicopathological Variation of Lauren Classification in Gastric Cancer

  2015cited by this paper
• Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma.

  2015influential reference
• Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer

  2014influential reference
• Prognostic Value of Tumor Size in Patients with Remnant Gastric Cancer: Is the Seventh UICC Stage Sufficient for Predicting Prognosis?

  2014cited by this paper
• Seventh Edition (2010) of the AJCC/UICC Staging System for Gastric Adenocarcinoma: Is there Room for Improvement?

  2013cited by this paper
• Regional activation of the cancer genome by long-range epigenetic remodeling.

  2013cited by this paper
• Multifactorial etiology of gastric cancer.

  2012cited by this paper
• Global cancer statistics

  2011cited by this paper
• Suitability of 7th UICC N Stage for Predicting the Overall Survival of Gastric Cancer Patients After Curative Resection in China

  2010cited by this paper
• Etiology of Gastric Cancer: What Is New?

  2005cited by this paper
• Allele-specific methylation analysis on upstream promoter region of H19 by methylation-specific PCR with confronting two-pair primers.

  2004cited by this paper

• GAS5 rs145204276 Ins/Del Polymorphism Is Associated with CRC Susceptibility in a Romanian Population

  2025cites this paper
• Long non-coding RNA GAS5 rs145204276 indel polymorphism and cancer risk: A systemic and meta-analysis review

  2023cites this paper
• Impact of LncRNA GAS5 Genetic Variants and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma Patients

  2022cites this paper
• The impact of GAS5 rs145204276 on development and prognosis of prostate cancer

  2022cites this paper
• Functional role of lncRNAs in gastrointestinal malignancies: the peculiar case of small nucleolar RNA host gene family

  2022cites this paper
• Growth arrest-specific 5 (GAS5) insertion/deletion polymorphism and cancer susceptibility in Asian populations

  2021cites this paper
• Association of LncRNA‐GAS5 gene polymorphisms and PBMC LncRNA‐GAS5 level with risk of systemic lupus erythematosus in Chinese population

  2021cites this paper
• Association between long non-coding RNA (lncRNA) GAS5 polymorphism rs145204276 and cancer risk

  2021cites this paper
• The relationships of genetic polymorphisms of the long noncoding RNA growth arrest-specific transcript 5 with uterine cervical cancer

  2020influential citation
• Long non-coding RNA GAS5 inhibits migration and invasion in gastric cancer via interacting with p53 protein.

  2020cites this paper
• Association between lncRNA GAS5, MEG3, and PCAT-1 Polymorphisms and Cancer Risk: A Meta-Analysis

  2020cites this paper
• LncRNA polymorphisms and upper gastrointestinal cancer risk.

  2020cites this paper
• OTT_A_221305 8421..8436

  2019cites this paper
• A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer.

  2019cites this paper
• Novel Tumor Suppressor lncRNA Growth Arrest-Specific 5 (GAS5) In Human Cancer

  2019cites this paper
• Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristics

  2019influential citation
• Growth arrest specific transcript 5 in tumorigenesis process: An update on the expression pattern and genomic variants.

  2019cites this paper
• A functional genetic variant in GAS5 lncRNA (rs145204276) modulates p27Kip1 expression and confers risk for gastric cancer

  2018cites this paper
• 5-bp insertion/deletion polymorphism in the promoter region of LncRNA GAS5 and cancer risk: A meta-analysis of 7005 cases and 8576 controls

  2018cites this paper
• A Functional Polymorphism rs145204276 in the Promoter of Long Noncoding RNA GAS5 Is Associated with an Increased Risk of Ischemic Stroke.

  2018cites this paper